Page 44 - Roche Diagnostics News Today

FDA approves test that enables patients with HER2-low metastatic breast cancer to be considered for treatment with antibody drug conjugate Enhertu.

A study of healthy transgender adults on estradiol or testosterone sheds news new light on a rarely studied group.

Roche (OTCQX:RHHBY) announced yesterday that it has promoted Matt Sause to the position of CEO of Roche Diagnostics.

The SARS-CoV-2 Rapid Antibody Test 2.0 is configured for broader use by healthcare professionals to now include vaccinated individuals, in addition to those...

Patients with heart failure and mitral regurgitation should get at least 6 months of optimized guideline-directed medical therapy before invasive mitral repair is considered, researchers say.

CHICAGO — A new diagnostic scale correlated with best corrected visual acuity and could serve as an alternative to evaluate disease activity in neovascular age-related macular degeneration, according to a study.

[297 Pages Report] Increasing burden of infectious diseases on healthcare system is a main concern across the globe and developing countries have heavy share of infectious disease burden. Burden of hepatitis C virus infection is growing over the years. According to Institute of Liver and Biliary Sciences India, appr...

The 2022 edition of the Innovation Forum brought together senior leaders and decision-makers from Dubai Health Authority and the healthcare industry to discuss key trends and developments in

The 2022 edition of the Innovation Forum brought together senior leaders and decision-makers from Dubai Health Authority and the healthcare industry to discuss...

The global point of care diagnostics market size was worth around USD 35.4 billion in 2021 and increase with a CAGR of approx 11.5 % over the forecast period